StrokeDx

Excited to return to the MedTech Innovator's Innovator Summit this week! It feels like just yesterday when StrokeDx's journey was transformed by this incredible program. The Innovator Summit was incredibly valuable, not just for the insights and mentorship but also for the opportunity to meet other #MTI cohort companies and learn from their experiences. I'm looking forward to meeting the new cohort and witnessing their innovative solutions. MTI has been a game-changer for us, and I'm eager to see how it will impact these new startups. See you all in Mountain View! #MedTechInnovator #Innovation #Healthcare #StrokeDx #Medtech #MedicalDevices

StrokeDx Secures $5M In Series Seed Prime Funding For Groundbreaking Stroke Technology Learn more & get our take 👇 https://lnkd.in/gsQpiBnR “This funding enables us to scale our detection and monitoring solution, empowering physicians and their patients with an effective tool for point-of-care cerebrovascular monitoring.” – Alex Ballatori, Co-Founder and CEO at StrokeDx “We believe in the potential of StrokeDx’s technology to change the diagnostic paradigm and ultimately improve outcomes for stroke patients.” – David J. Kim, M.D., Managing Director at DigiTx Partners #funding #stroke #SoHCNews

StrokeDx Closes $5 Million Seed Round https://lnkd.in/gBW7xWdY Follow citybiz on LinkedIn - https://lnkd.in/eBgXKiz8 StrokeDx DigiTx Partners FreeFlow Ventures David J. Kim, M.D. Alex Ballatori #StrokeDx #Funding #FundRaise #cerebrovascular #monitoring #FreeflowVentures

StrokeDx raised $5,000,000 in their Seed Round-Congrats Alex Ballatori Full Round Info: https://lnkd.in/gXm64NrT Round Investors: DigiTx Partners, FreeFlow Ventures and other existing investors

#fundingalert 💼Company: StrokeDx 💰Funding: $5Million ⚡Round: Seed 👥Investors: DigiTx Partners, FreeFlow Ventures and other existing investors with extensive accomplishments across neuroradiology, stroke, and medical devices. StrokeDx is at the forefront of developing next-generation stroke detection technology. Their mission is to provide early, accurate, and accessible stroke monitoring and detection solutions to improve patient outcomes and reduce the global burden of stroke. This latest investment will support further clinical validation of StrokeDx’s groundbreaking technology and the expansion of its commercial efforts. Alex Ballatori, David J. Kim, M.D., Shane Shahrestani, MD, PhD, Alex Ballatori Read more - https://lnkd.in/gJ8aeVaC To share your startup story write us on - [email protected] #StrokeDx #strokedetection #technology #commercial #funding #fundingnews #startup #startupnews #news #Startuprise

Thank you, The Mullings Group, for your support!

Matt Kaufman - Thank you for all your incredible work supporting the lives of stroke patients and their families. We look forward to seeing you soon!

We are thrilled to announce that StrokeDx has successfully raised $5 million in Series Seed Prime funding to advance our groundbreaking #stroke technology! ✔ Round led by DigiTx Partners, with participation from Freeflow Ventures and other existing investors with domain expertise ✔ David J. Kim, M.D., Managing Director of DigiTx Partners, joins our board ✔ This investment will fund further clinical validation and expansion of our commercial efforts StrokeDx is dedicated to developing advanced, portable, non-invasive cerebrovascular monitoring technology to improve stroke outcomes for millions of at-risk individuals. With this funding, we can enhance our early detection and rapid monitoring solutions, providing a scalable, equitable approach to healthcare accessibility. “Stroke affects millions globally, leading to significant mortality and long-term disability. This funding enables us to scale our detection and monitoring solution, empowering physicians and their patients with an effective tool for point-of-care cerebrovascular monitoring. Early intervention can significantly reduce the impact of stroke, shifting the focus from treatment to prevention,” said Alex Ballatori, Co-Founder and CEO of StrokeDx. “We believe in the potential of StrokeDx’s technology to change the diagnostic paradigm and ultimately improve outcomes for stroke patients. By providing accessible, advanced technology, we can reach millions of at-risk individuals, potentially saving countless lives and reducing the burden on healthcare systems around the world,” said David J. Kim, MD, Managing Director of DigiTx Partners.  Press Release: https://lnkd.in/gs8agwM2 #Stroke #NeuroTech #DigitalHealth #MedTech #HealthTech #MedicalInnovation #Healthcare #StrokeAwareness #Funding #VentureCapital #HealthEquity #StrokeDx

I am incredibly grateful to Matt Kaufman for hosting me on #thefamilybusiness podcast. I loved our conversation, and I'm honored by your kind words and support. Thank you for all that you do for stroke patients and their families. Family has always been my greatest motivation. My parents' journey and their relentless pursuit of excellence have been the cornerstone of my drive. It was a privilege to share this story and the innovative work we're doing at StrokeDx with you and your audience. I want to give a special shoutout to my co-founder, Shane Shahrestani, MD, PhD, whose brilliance and dedication have been instrumental in our journey. Together, we aim to revolutionize #stroke care with our novel, portable, affordable technology. Thank you, Matt, for your encouragement and for highlighting the importance of family, innovation, and the future of healthcare. #neurovascular #family #medtech #medtechinnovator #MTI #healthcare #innovation #StrokeDx

Thank you for sharing, StartupCouncil.org!